European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- Jun 2026

Manufacturers must adhere to specific "Production" and "Test" sections to satisfy regulatory bodies like the European Directorate for the Quality of Medicines & HealthCare (EDQM) . 1. Disintegration Testing (General Chapter 2.9.1)

This article provides an in-depth analysis of Ph. Eur. Monograph 0478, exploring its scope, core quality requirements, critical testing methodologies, and its profound impact on pharmaceutical manufacturing and regulatory compliance. 1. Scope and Definition of Monograph 0478

Note: This standard explicitly excludes lozenges, chewable oral pastes, or tablets intended for alternative routes like implants or vaginal insertion, which are covered by separate dedicated monographs. Production and Manufacturing Controls European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

user wants a long article about the European Pharmacopoeia monograph "Tablets" with number 0478. I need to conduct a comprehensive search to gather information on this specific monograph, its role in pharmaceutical quality control, and related contexts. The search plan includes several steps, such as verifying the 0478 number, gathering technical details, finding the official text, understanding European Pharmacopoeia functions, and covering related topics like harmonization and regulatory use. I will start with the first set of searches. search results have provided several relevant sources. The first result is a page from drugfuture.com that appears to contain the full text of the monograph. The second result from gmp-compliance.org discusses revisions to the monograph. The third result from faq.edqm.eu provides context on disintegration tests. The fourth result from ages.at discusses a study on tablet divisibility. The fifth result from journal.pda.org discusses weight uniformity. The sixth result from nhathuocngocanh.com provides a definition and characters of tablets. The seventh result from rrrry.com is a Chinese news article about the revision. The eighth result from ouci.dntb.gov.ua provides a reference. The search on edqm.eu yielded FAQ pages. The search on pheur.edqm.eu yielded no results. The search on general monograph Tablets yielded several results including a PharmTech article, EDQM training modules, and updates. The search on content uniformity and dissolution testing yielded relevant results. The search on general monograph Tablets dosage form yielded some relevant pages. The search on ICH Q4B yielded results about harmonization. Now I need to open the key pages to gather detailed information.'ve gathered a significant amount of information from the opened pages. The drugfuture.com page provides the full text of the monograph. The gmp-compliance.org page details revisions. The faq.edqm.eu page discusses disintegration tests. The ages.at page discusses a study on tablet divisibility. The nhathuocngocanh.com page provides a definition. The pharmtech.com pages discuss tablet splitting and dosage uniformity. The EDQM training module page provides context. The gmp-navigator.com page provides details on revisions. The ICH Q4B page discusses harmonization. I also have the British Pharmacopoeia pages. Now I need to gather more information on the European Pharmacopoeia's role, the EDQM, and the legal status. I'll also search for updates or revisions beyond 2018. search results have provided additional information on the legal status, EDQM, and revisions. I have a good amount of material to work with. The user's question has high authority requirements, I should prioritize using official sources like the EDQM and official pharmacopoeia texts. The article should be comprehensive, covering the definition, categories, production requirements, subdivision rules, quality tests, legal status, harmonization, recent updates, and practical implications. I will structure the article with an introduction, the definition and types of tablets, production requirements, subdivision of tablets, quality control tests, legal and regulatory framework, harmonization with other pharmacopoeias, recent revisions and updates, and a conclusion. I will cite the sources appropriately. Now I will start writing the article. tablet is the most common and widely recognized dosage form in modern medicine, yet the quality standards governing its manufacture are exceptionally rigorous and legally binding. At the heart of these standards for Europe and beyond lies the . This document is far more than a simple definition; it is the comprehensive regulatory blueprint that dictates how tablets are designed, produced, and tested to ensure patient safety.

Measures the time required for tablets to break up in a liquid medium. Standard uncoated tablets typically must disintegrate within 15 minutes . Scope and Definition of Monograph 0478 Note: This

: A critical test that measures how the active substance is released into a liquid medium over time. Ph. Eur. 0478 mandates a suitable dissolution test unless a disintegration test is otherwise justified. Disintegration (2.9.1)

The monograph dictates that the excipients used must be safe, non-toxic, and must not adversely affect the therapeutic efficacy or bioavailability of the active pharmaceutical ingredient (API). Excipients typically include diluents, binders, disintegrants, glidants, lubricants, and coloring or flavoring agents. Minimizing Microbial Contamination For sugar-coated tablets

: Including prolonged-release and delayed-release (gastro-resistant) forms to control where or when the drug is absorbed. Reference Standards

In the world of modern medicine, the tablet is the undisputed king. It is the default delivery system for the vast majority of active pharmaceutical ingredients (APIs). Yet, behind every unassuming white disc lies a complex engineering challenge: how do you ensure that a powder becomes a solid, survives the journey in a bottle, and then dissolves perfectly inside the human body?

: Determines the resistance of the tablet surface to abrasion and impact. A sample roll in a specialized drum must demonstrate that weight loss does not exceed strict limits.

For sugar-coated tablets, use the core mass; for film-coated, use the total mass.